Establishment and Validation of an Integrated Model to Predict Postoperative Recurrence in Patients With Atypical Meningioma
Open Access
- 7 October 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Abstract
Background: This study aims to establish an integrated model based on clinical, laboratory, radiological, and pathological factors to predict the postoperative recurrence of atypical meningioma (AM).Materials and Methods: A retrospective study of 183 patients with AM was conducted. Patients were randomly divided into a training cohort (n = 128) and an external validation cohort (n = 55). Univariable and multivariable Cox regression analyses, the least absolute shrinkage and selection operator (LASSO) regression analysis, time-dependent receiver operating characteristic (ROC) curve analysis, and evaluation of clinical usage were used to select variables for the final nomogram model.Results: After multivariable Cox analysis, serum fibrinogen >2.95 g/L (hazard ratio (HR), 2.43; 95% confidence interval (CI), 1.05–5.63;p = 0.039), tumor located in skull base (HR, 6.59; 95% CI, 2.46-17.68;p < 0.001), Simpson grades III–IV (HR, 2.73; 95% CI, 1.01–7.34;p = 0.047), tumor diameter >4.91 cm (HR, 7.10; 95% CI, 2.52–19.95;p < 0.001), and mitotic level ≥4/high power field (HR, 2.80; 95% CI, 1.16–6.74;p = 0.021) were independently associated with AM recurrence. Mitotic level was excluded after LASSO analysis, and it did not improve the predictive performance and clinical usage of the model. Therefore, the other four factors were integrated into the nomogram model, which showed good discrimination abilities in training cohort (C-index, 0.822; 95% CI, 0.759–0.885) and validation cohort (C-index, 0.817; 95% CI, 0.716–0.918) and good match between the predicted and observed probability of recurrence-free survival.Conclusion: Our study established an integrated model to predict the postoperative recurrence of AM.Keywords
This publication has 39 references indexed in Scilit:
- Development and Validation of a Nomogram for Predicting Survival in Patients With Resected Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2015
- Benign versus atypical meningiomas: Risk factors predicting recurrenceNeurologia i Neurochirurgia Polska, 2015
- Nomogram Predicting Long-Term Survival After D2 Gastrectomy for Gastric CancerJournal of Clinical Oncology, 2012
- Atypical and Malignant Meningioma: Outcome and Prognostic Factors in 119 Irradiated Patients. A Multicenter, Retrospective Study of the Rare Cancer NetworkInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor‐2 (FGF‐2)Journal of Thrombosis and Haemostasis, 2007
- Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagusJournal of Gastroenterology and Hepatology, 2007
- Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell–mediated elimination of tumor cellsBlood, 2005
- Tumors and FibrinogenAnnals of the New York Academy of Sciences, 2001
- Involvement of lnterleukin-6 in the Elevation of Plasma Fibrinogen Levels in Lung Cancer PatientsJapanese Journal of Clinical Oncology, 1998
- Unspecific metabolic blood parameters as used in clinical routine may differentiate malignant from benign cerebral tumorsCancer Letters, 1995